| Megan Jane Niehaus, OTR/L | |
|
1813 Willow St Ste 1b, Vincennes, IN 47591-4279 | |
| (812) 316-0072 | |
| Not Available |
| Full Name | Megan Jane Niehaus |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 1813 Willow St Ste 1b, Vincennes, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164291753 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 31008281A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Jane Niehaus, OTR/L 102 Lakewood Dr, Vincennes, IN 47591-3736 Ph: (812) 890-6735 | Megan Jane Niehaus, OTR/L 1813 Willow St Ste 1b, Vincennes, IN 47591-4279 Ph: (812) 316-0072 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced today that the Company has agreed to be a party to the settlement between Histostem, Incorporated, a Delaware Corporation ("Histostem USA") and Histostem Corporation, a Korean Corporation ("Histostem Korea"). The agreement is contingent upon the close of the SCII and Histostem Korea merger, and specifically, the agreement is contingent that at the close of the merger, SCII will acquire no less than 90% of the total fully diluted equity of Histostem Korea.
Researchers funded by the National Institute of Mental Health (NIMH), have found that requests from patients for medications have a "profound effect" on physicians prescribing for major depression and adjustment disorder. These findings indicate that direct-to-consumer (DTC) marketing of prescription medications for depression may exert significant influence on treatment decisions.
The CRISPR-Cas9 gene editing system may be able to restore the effectiveness of first-line chemotherapies used to treat lung cancer by deleting or "knocking out" a gene in cancer tumors that helps the tumors develop resistance to the drugs.
UNAIDS Executive Director Michel Sidibe on Saturday "told a Vatican conference [Pope Benedict XVI] had opened the door to greater dialogue with his groundbreaking comments on condoms and HIV prevention - even as Vatican officials stressed abstinence and marital fidelity as the best prevention," the Associated Press reports.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that in collaboration with OXiGENE, Professor Gordon Rustin and colleagues from the Mount Vernon Cancer Research Centre, UK and other institutions in the United Kingdom, reported positive final data from an investigator-sponsored Phase 1 study of OXi4503 in patients with solid tumors.
› Verified 2 days ago
Nathan Harrison, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 723 E Ramsey Rd, Vincennes, IN 47591 Phone: 812-882-8787 | |
Mrs. Christine M Cavanaugh, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3801 Old Bruceville Rd, Vincennes, IN 47591 Phone: 812-886-4677 Fax: 812-866-4678 | |
Kristina Lynn Hirsch, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3801 Old Bruceville Rd, Vincennes, IN 47591 Phone: 812-882-1783 | |
Tiffany Renee Neukam, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 College Ave., Vincennes, IN 47591 Phone: 502-412-5847 | |
Mrs. Laura Elizabeth Neumann, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1215 N Mulberry Ln, Vincennes, IN 47591 Phone: 617-501-8381 | |
Mr. Jacob Palmer Adams, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2860 E State Road 61, Vincennes, IN 47591 Phone: 812-887-1219 | |
Mr. Dwight Eugene Bolejack, OCCUPATIONAL THERAPI Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3801 Old Bruceville Rd, Vincennes, IN 47591 Phone: 812-886-4677 Fax: 812-886-4678 |